Whole Blood mRNA Expression Profiling of Crohn's Disease in the Certifi Ustekinumab Study Discriminates Clinical Subtypes

被引：0
|
作者：
Li, Katherine
Brodmerkel, Carrie
Telesco, Shannon
Ma, Keying
Gasink, Christopher
机构：
来源：
GASTROENTEROLOGY | 2013年 / 144卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S179 / S179
页数：1
相关论文
共 50 条
  • [41] Clinical Response to Ustekinumab in Crohn's Disease: Results from an Academic Inflammatory Bowel Disease Center
    Novikov, Aleksey
    Sriram, Nandita
    Rosen, Melissa
    Scherl, Ellen
    Bosworth, Brian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S535 - S535
  • [42] Expression of glucocorticoid receptors mRNA in patients with Crohn's disease (CD)
    Towers, R
    Naftali, T
    Gabay, G
    Carlibach, M
    Klein, A
    Novis, B
    GASTROENTEROLOGY, 2004, 126 (04) : A214 - A214
  • [43] Machine learning gene expression predicting model for ustekinumab response in patients with Crohn's disease
    He, Manrong
    Li, Chao
    Tang, Wanxin
    Kang, Yingxi
    Zuo, Yongdi
    Wang, Yufang
    IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (04) : 1529 - 1540
  • [44] Association of CARD15 variants with clinical subtypes of Crohn's disease:: A study of 630 cases
    Onnie, Clive
    Fisher, Sheila
    Forbes, Alastair
    Sanderson, Jeremy
    Lewis, Cathryn
    Mathew, Christopher
    GASTROENTEROLOGY, 2006, 130 (04) : A592 - A592
  • [45] Feasibility of a Clinical Decision Support Tool for Ustekinumab to Predict Clinical Remission and Relapse in Patients With Crohn's Disease: A Multicenter Observational Study
    Park, Jihye
    Chun, Jaeyoung
    Yoon, Hyuk
    Cheon, Jae Hee
    INFLAMMATORY BOWEL DISEASES, 2023, 29 (04) : 548 - 554
  • [46] Ustekinumab serum concentrations are associated with clinical outcomes in Crohn's disease - a regional multi-center pilot study
    Thomann, Anne Kerstin
    Schulte, Lucas-Alexander
    Globig, Anna-Maria
    Hoffmann, Peter
    Klag, Thomas
    Itzel, Timo
    Teufel, Andreas
    Schreiner, Rupert
    Scheffe, Nina
    Ebert, Matthias Philip
    Wehkamp, Jan
    Gauss, Annika
    Hasselblatt, Peter
    Klaus, Jochen
    Reindl, Wolfgang
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (05): : 439 - 444
  • [47] EFFECT OF MAINTENANCE USTEKINUMAB ON CORTICOSTEROID-FREE CLINICAL OUTCOMES IN PATIENTS WITH CROHN'S DISEASE
    Feagan, Brian G.
    Gasink, Christopher
    Pollack, Paul
    Jacobstein, Douglas
    Gao, Long-Long
    Johanns, Jewel
    Miao, Ye
    Targan, Stephan R.
    Ghosh, Subrata
    GASTROENTEROLOGY, 2017, 152 (05) : S595 - S595
  • [48] Effect of maintenance Ustekinumab on corticosteroid-free clinical outcomes in patients with Crohn's disease
    Feagan, B. G.
    Gasink, C.
    Pollack, P.
    Jacobstein, D.
    Gao, L. -L.
    Johanns, J.
    Miao, Y.
    Targan, S.
    Ghosh, S.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S359 - S360
  • [49] Effectiveness and safety of ustekinumab dose escalation in Crohn's disease: a multicenter observational study
    Olmedo-Martin, Raul
    Vazquez-Moron, Juan Maria
    Martin-Rodriguez, Maria del Mar
    Lazaro-Saez, Marta
    Hernandez-Martinez, Alvaro
    Arguelles-Arias, Federico
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2023, 115 (12) : 686 - 692
  • [50] Relation between Crohn's disease phenotype and response to ustekinumab in Stockholm - the STOCUSTE study
    Bello, F.
    Muhsen, S.
    Sabhan, H.
    Borin, A.
    Johansson, F.
    Hoog, C.
    Forsberg, O.
    Wennerstrom, C.
    Soderman, C.
    Lordal, M.
    Almer, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1679 - I1681
12345